North America Healthcare 3D Printing Market, By Modality (Standalone, Integrated), Components (Material, Hardware, Software, Services), Technology (Bioprinting, Droplet Deposition/Extrusion-Based Technologies, Photopolymerization, Laser Beam Melting, Electron Beam Melting (EBM), 3DP/Adhesion Bonding/Binder Jetting, Others), Application (Medical, Surgical, Pharmaceutical, Others), End User (Medical & Surgical Centers, Research Centers and Academic Institutions, Pharmaceutical & Biotechnology Companies, Others) – Industry Trends and Forecast to 2030.
North America Healthcare 3D Printing Market Analysis and Size
The demand for healthcare 3D printing market has increased in developed and developing countries and this is due to the emergence of COVID-19 and the growing need for medical devices. The rise in orthopedic and dental anomalies is expected to drive the growth of the healthcare 3D printing market. The high cost of 3D printing is expected to restrain the growth of the market. The strategic initiative of the major market players is expected to have a great opportunity for the growth of the medical 3D printing market.
Data Bridge Market Research analyses that the North America healthcare 3D printing market which was USD 1084.58 million in 2022, would rocket up to USD 3217.03 million by 2030, and is expected to undergo a CAGR of 16.0% during the forecast period. This indicates the market value. “Standalone” dominates the modality segment of the North America healthcare 3D printing market due to the software’s accessibility features it provides to the users. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Healthcare 3D Printing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Modality (Standalone, Integrated), Components (Material, Hardware, Software, Services), Technology (3D Bioprinting, Droplet Deposition/Extrusion-Based Technologies, Photopolymerization, Laser Beam Melting, Electron Beam Melting (EBM), 3DP/Adhesion Bonding/Binder Jetting, Others), Application (Medical, Surgical, Pharmaceutical, Others), End User (Medical & Surgical Centers, Research Centers and Academic Institutions, Pharmaceutical & Biotechnology Companies, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
Carbon, Inc. (U.S.), Stratasys Ltd. (Israel), 3D Systems, Inc. (U.S.), Organavo Holdings Inc. (U.S.), CELLINK GLOBAL (Sweden), EOS (Germany), ENVISIONTEC, INC. (U.S.), Materialise (Belgium), Renishaw plc (U.K.), SLM Solutions (Germany), FIT AG (Germany), Prodways Technologies (a subsidiary of Prodways Group) (France), Advanced Solutions Life Sciences, LLC (U.S.), 3D Biotek (U.S.), Aprecia Pharmaceuticals (U.S.), Nano3D Biosciences (U.S.), TeVido BioDevices (U.S.), Stratasys (Israel), BioBots (U.S.), Allevi, Inc. (U.S.) and Wacker Chemie AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
3D printing, also known as additive manufacturing, is a layer-by-layer approach to turning a three-dimensional digital file into actual custom medical devices and products. A computer-aided design (CAD) package is created with 3D printing software using a 3D scanner, digital camera, or 3D modelling software. Before the thing is printed, the 3D model developed with CAD can be updated and modified, allowing it to be authenticated.
North America Healthcare 3D Printing Market Dynamics
Drivers
- Increasing Demand for Personalized Healthcare Solutions
Growing demand for personalized healthcare solutions is a major driver of the North America healthcare 3D printing market. 3D printing enables the production of patient-specific medical devices and implants that improve treatment outcomes, reduce risks and improve patient satisfaction.
- Rising Prevalence of Chronic Diseases and Ageing Population
The prevalence of chronic diseases such as cardiovascular diseases, orthopedic diseases and dental problems, along with the aging population of North America, increases the demand for 3D printing in healthcare. 3D printing offers efficient and cost-effective solutions to produce patient-specific implants, prostheses, and surgical tools that meet the needs of this demographic.
- Advancements in Material Science and Bioprinting
Advances in materials science and bioprinting techniques have expanded the possibilities of 3D printing in healthcare. The development of bio-ink and biocompatible materials enables the creation of 3D-printed tissues, organs and scaffolds for regenerative medicine, tissue engineering and drug testing, fueling the growth of the healthcare 3D printing market
- Growing investment in healthcare facilities
Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Expansion of Medical Device Customization
The ability of 3D printing to create customized medical devices opens up opportunities for companies to meet the specific needs of patients. This includes custom implants, prostheses, orthopaedic and surgical tools. The market will benefit from this trend by providing customized solutions that improve patient outcomes and satisfaction.
- Collaboration with Pharmaceutical Companies
Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Restraints/ Challenges
- High Cost of Equipment and Materials
The initial costs of 3D printing equipment, software and materials can be significant, limiting the adoption of 3D printing in healthcare, especially for smaller healthcare facilities and providers. High investment costs and constant maintenance may limit the market growth.
- Complex Regulatory Environment
The regulatory environment for 3D printing in healthcare is complex and evolving. Complying with regulatory requirements and obtaining necessary approvals can be difficult due to the lack of standard guidelines and different regulations in different jurisdictions. Navigating the regulatory landscape and ensuring compliance can be a significant challenge for companies operating in this market.
- Limited Adoption by Healthcare Institutions
The adoption of 3D printing in healthcare can face resistance and challenges at the institutional level. Integrating 3D printing into existing healthcare workflows, infrastructure and practices requires investment, training and change management. Convincing healthcare institutions of the long-term benefits and return on investment of 3D printing for healthcare can be a significant challenge.
This healthcare 3D printing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the healthcare 3D printing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2021, ENVISIONTEC, INC. announced that it has been acquired by the Desktop Metal, Inc. in order to maximize the production of polymer additive manufacturing. This acquisition by the company has increased its sales and demand in the market leading to increased demand for its products in the market
- In January 2020, 3D Systems, a company that designs, manufactures and sells 3D printers in Rock Hill, South Carolina, developed tissue and scaffold bioprinting processes for third-party companies. CollPlant Biotechnologies with CLGN.
North America Healthcare 3D Printing Market Scope
The healthcare 3D printing market is segmented on the basis of modality, components, technology, application,and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Modality
- Standalone
- Integrated
Components
- Medical
- Hardware
- Software
- Services
Technology
- Bioprinting
- Droplet Deposition/Extrusion-Based Technologies
- Photopolymerization
- Laser Beam Melting
- Electron Beam Melting (EBM)
- 3DP/Adhesion Bonding/Binder Jetting
- Others
Application
- Medical
- Surgical
- Pharmaceutical
- Others
End User
- Medical & surgical centers
- Research centers and academic institutions
- Pharmaceutical & biotechnology companies
- Others
North America Healthcare 3D Printing Market Regional Analysis/Insights
The healthcare 3D printing market is analysed and market size insights and trends are provided by country, modality, components, technology, application,, and end user as referenced above.
The countries covered in the healthcare 3D printing market report are U.S., Canada and Mexico in North America.
The U.S. will dominate the healthcare 3D printing market due to the increase in the number of major market players and the development of manufacturing facilities in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The North America healthcare 3D printing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America healthcare 3D printing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America healthcare 3D printing market. The data is available for historic period 2010-2020.
Competitive Landscape and North America Healthcare 3D Printing Market Share Analysis
The North America healthcare 3D printing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to North America healthcare 3D printing market.
Some of the major players operating in the North America healthcare 3D printing market are:
- Carbon, Inc. (U.S.)
- Stratasys Ltd. (Israel)
- 3D Systems, Inc. (U.S.)
- Organavo Holdings Inc. (U.S.)
- CELLINK GLOBAL (Sweden)
- EOS (Germany)
- ENVISIONTEC, INC. (U.S.)
- Materialise (Belgium)
- Renishaw plc (U.K.)
- SLM Solutions (Germany)
- FIT AG (Germany)
- Prodways Technologies (a subsidiary of Prodways Group) (France)
- Advanced Solutions Life Sciences, LLC (U.S.)
- 3D Biotek (U.S.)
- Aprecia Pharmaceuticals (U.S.)
- Nano3D Biosciences (U.S.)
- TeVido BioDevices (U.S.)
- BioBots (U.S.)
- Allevi, Inc. (U.S.)
- Wacker Chemie AG (Germany)
SKU-